ll OPEN ACCESS Clinical and Translational Report Cell Metabolism 34, 12341247, September 6, 2022 1235 Figure 1
There's also data suggesting that in some cases, people who take GLP-1s for several years can start to experience a waning effect - perhaps a drug resistance - where they start to regain some weight, even while taking the medication
In some cases, the tendon can even tear completely known as a rupture
10.3389/fimmu.2024.1450414 74 NyssenO
Emerging evidence suggests that GLP-1 RAs may have clinical implications beyond a weight loss and glycemic control indication, including cardiovascular disease, nonalcoholic fatty liver disease, and recurrent alcohol use disorder
N Engl J Med 2008;359:1464-76.ArticlePubMed 176